May. 9, 2018—Many computer monitors throughout Vanderbilt University Medical Center will soon be replaced with new 24-inch monitors.
May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.
May. 7, 2018—The APOE gene, the strongest genetic risk factor for Alzheimer’s disease, may play a more prominent role in disease development among women than men, according to new research from the Vanderbilt Memory and Alzheimer’s Center.
May. 3, 2018—Its people are Vanderbilt University Medical Center’s greatest asset, Jeff Balser, MD, PhD, President and Chief Executive Officer of VUMC and Dean of Vanderbilt University School of Medicine, reminded those in attendance at the May 2018 Leadership Assembly.
May. 3, 2018—Monroe Carell Jr. Children’s Hospital at Vanderbilt is now a fully accredited Primary Ciliary Dyskinesia (PCD) Foundation Clinical and Research Centers Network site, one of 40 in the United States and Canada.
May. 3, 2018—A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.
May. 3, 2018—The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6.
May. 3, 2018—Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are: